LAB ROUNDUP 7 May – awards, partnerships, appointments and acquisitions
7 May 2023
The PCCP Emerging Investigator Award for emerging scientists working in physical chemistry, chemical physics or biophysical chemistry making outstanding contributions to their field at an early stage of their career has been awarded to Professor Li-Chiang Lin of National Taiwan University.
Shortlisted nominees for the award will have the opportunity to submit an article to the 2023 Emerging Investigators themed collection.
Contract research, development, and manufacturing organisation dedicated to viral vector and nucleic acids production Exothera announced a strategic partnership with biotech Quantoom Biosciences, to access Quantoom’s Nfinity technology. Exothera claims it is the first CDMO to offer this off-the-shelf process for the continuous production of RNA as a service, which it will provide via rough its new Exothera Nucleic Acids business unit.
Phesi has launched its Digital Patient Profile catalogue to provide granular data on the typical patient for 28 disease areas including Alzheimer’s, breast cancer, stroke, COVID-19, Crohn’s disease and ulcerative colitis. It is based on data from 60 million patients and 485,000 clinical trials in Phesi’s Trial Accelerator platform. Phesi adds it can generate DPPs for more than 4,000 disease areas.
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has appointed Kenneth Hitchner Chairman of its Board of Directors. His background includes 28 years in Goldman Sachs’ biopharmaceutical and medical device sectors. Also membership of the Global Management committee and a tenure as Chairman and CEO of Asia Pacific, excluding Japan, from 2013 to 2019.
Esperovax, Inc. the oral RNA vaccine and therapeutic technology company specializing in oral mRNA-based medicines, appointed Dr. Robin Robinson as President and Chief Executive Officer.
Health and toxicology diagnostics leader Clinisys has acquired laboratory information management systems provider to environmental, water, wastewater and other analytical testing laboratories Promium.
International subsea rental equipment and solutions specialist Ashtead Technology (pictured) has signed an exclusive rental agreement with France-based i2S, specialists in underwater robotics and imaging solutions. Ashtead Technology will have access to i2S’s Orphie systems, high-specification cameras that can be used by ROV and divers to improve observation in turbid waters. Orphie technology can observe objects at a distance three times greater than many cameras, producing real-time images to support underwater inspection operations.
